{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:25:45Z","timestamp":1758446745367,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.metabol.2007.10.020","type":"journal-article","created":{"date-parts":[[2008,4,27]],"date-time":"2008-04-27T07:48:18Z","timestamp":1209282498000},"page":"593-597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation"],"prefix":"10.1016","volume":"57","author":[{"given":"Paola","family":"Canibus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Faloia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Piva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andi","family":"Mu\u00e7ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Serenelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Piero","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Piva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2001","series-title":"Diabete e sindrome plurimetabolica","author":"Muggeo","key":"10.1016\/j.metabol.2007.10.020_bib1"},{"year":"2001","series-title":"Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III)","author":"National Institute of Health","key":"10.1016\/j.metabol.2007.10.020_bib2"},{"key":"10.1016\/j.metabol.2007.10.020_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2007.10.020_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ecl.2004.03.005","article-title":"The metabolic syndrome: prevalence in worldwide populations","volume":"33","author":"Cameron","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.metabol.2007.10.020_bib5","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archinte.164.10.1066","article-title":"Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women","volume":"164","author":"Hu","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2007.10.020_bib6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/sj.ijo.0802381","article-title":"Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study","volume":"27","author":"Bonora","year":"2003","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.1016\/j.metabol.2007.10.020_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Heart and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2007.10.020_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.numecd.2004.09.002","article-title":"Prevalence of the metabolic syndrome among Italian adults according to ATP III definition","volume":"15","author":"Miccoli","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2007.10.020_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.10.020_bib10","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total cardiovascular disease mortality in middle aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2007.10.020_bib11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s001250100615","article-title":"The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes","volume":"44","author":"Isomaa","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.10.020_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1210\/jc.2006-0513","article-title":"Metabolic syndrome: a multiplex cardiovascular risk factor","volume":"92","author":"Grundy","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.metabol.2007.10.020_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/diacare.28.4.873","article-title":"Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention","volume":"28","author":"Rana","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.10.020_bib14","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/01.CIR.0000014967.78190.BB","article-title":"Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery. Bypass Angioplasty Revascularization Investigation","volume":"105","author":"Kip","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.10.020_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0735-1097(95)00496-3","article-title":"Potential mechanism promoting restenosis in diabetic patients","volume":"27","author":"Aronson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2007.10.020_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1056-8727(01)00190-8","article-title":"Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation: intravascular ultrasound study","volume":"16","author":"Takagi","year":"2002","journal-title":"J Diabetes Complication"},{"key":"10.1016\/j.metabol.2007.10.020_bib17","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000034045.36219.12","article-title":"Angiographic findings of the multicenter Randomized Study with the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size","volume":"106","author":"Regar","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.10.020_bib18","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.0000129767.45513.71","article-title":"Impact of sirolimus-eluting stent on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesion) substudy","volume":"109","author":"Moussa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.10.020_bib19","doi-asserted-by":"crossref","first-page":"97A","DOI":"10.1016\/S0735-1097(04)90407-X","article-title":"Sirolimus-eluting stent implantation in routine clinical practice: a 12-month follow-up report from the international e-CYPHER registry","volume":"43","author":"Lotan","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2007.10.020_bib20","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":". One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.10.020_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.311.6998.158","article-title":"Waist circumference as a measure for indicating need for weight management","volume":"311","author":"Lean","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2007.10.020_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.10.020_bib23","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.10.020_bib24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.94.6.1247","article-title":"Patterns and mechanism of in-stent restenosis. A serial intravascular ultrasound study","volume":"94","author":"Hoffman","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.10.020_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0735-1097(00)00799-3","article-title":"Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients. A serial intravascular ultrasound study","volume":"36","author":"Takagi","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.metabol.2007.10.020_bib26","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/01.CIR.0000095272.67948.17","article-title":"Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting","volume":"108","author":"Piatti","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.10.020_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMp068300","article-title":"Debating the risks of drug-eluting stents","volume":"356","author":"Shuchman","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.metabol.2007.10.020_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2007.10.020_bib29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.metabol.2007.10.020_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.amjcard.2004.11.020","article-title":"Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)","volume":"95","author":"Nikolsky","year":"2005","journal-title":"Am J Cardiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049507003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049507003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:26:10Z","timestamp":1758425170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049507003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0026049507003800"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2007.10.020","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2007.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}